Fortis Malar Hospitals Share Price

Fortis Malar Hospital Limited, formerly known as Malar Hospital Limited was established on April 12, 1989 to set up, manage and operate a multispecialty hospital. Company is a subsidiary of Fortis Hospitals Limited and Fortis Healthcare Limited is the Intermediate Holding Company. Later, the Company changed its name to Fortis Malar Hospital Limited on December 21, 2010. The Hospital building was owned by a fellow subsidiary, Fortis Health Management Limited (FHML) in early 2008. The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multispeciality healthcare services. With a total bedstrength of 160, including 40 ICU/CCU/RTU beds, the hospital focuses on providing comprehensive medical care in the areas of Cardiology and Cardiac Surgery, Neuro Surgery, Gynaecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal MedicineAll the above departments are fully became operational under phase I of the project. The second phase of the project envisages enhacement of the number of beds from 100 to 250 beds at an cost of Rs.2120 lacs. To part the project the company came into rights issues during 1995. The Hospital have started performing Cardio Thoracic surgeries with effect from 13102003. Dr.K M Cherian is leading this cardio Thoracic department. He has won several awards and honors including Padmashree award from the Government. Dr.K M Cherian has conducted around 26,200 cardio thoracic cases including infant heart surgery, heart transplants, paediatric heart transplants and heart and lung transplants. This type of surgery will bring more revenue to the hospital in the comming years. With Dr.K M Cherian at command of cardio thoracic team, the future looks bright.On 7th September 2007 the Company and the Promoters of the Company entered into a Loan, Share Subscription and Share Purchase Agreement (LSSSPA) with International Hospital Ltd, a wholly owned subsidiary of Fortis Healthcare Limited and Oscar Investments Ltd (Acquirer) for the sale of 39,00,000 Equity Shares by the Promoters of the Company and for availing a loan of Rs 14 crores fromthe Acquirers, convertible into Equity Shares of the Company. Further, the Acquirer Companies acquired 39,00,000 Equity Shares from the Promoters of the Companies on 18th February 2008 which together with their existing holding, constituted 62.17% of the Share Capital of the Company. The Management and Control of Affairs of Company is now with the Acquirers, who consequently shall act as Promoters of the Company.On, 7th July, 2009, Company incorporated a wholly owned subsidiary viz. Malar Stars Medicare Limited.The Board of Directors of Company on August 19, 2016 approved a Composite Scheme of Arrangement and Amalgamation between Company, Fortis Healthcare Limited (FHL), SRL Limited (SRL) and their respective Shareholders and Creditors for (i) the transfer of the undertaking, business and operations of the Company as a going concern, by way of slump sale, from the Company to FHL, (ii) the transfer by way of a demerger of the undertakings, business, activities and operations of FHL, pertaining to diagnostics business of FHL (Demerged Undertaking) to Company, and consequent issue of Equity Shares by Company to Shareholders of FHL (iii) amalgamation of all the undertakings and entire business of SRL with Company and dissolution of SRL without winding up the consequent issue of equity shares by Company to the Shareholders of SRL and the cancellation of equity shares of SRL held by Company and various other matters consequential or otherwise integrally connected therewith. Further, National Company Law Tribunal, Chandigarh, vide its order dated June 15, 2018 approved the scheme as withdrawn and accordingly, as on date, the Scheme was terminated by Company, SRL and FHL.Pursuant to execution of Share Subscription Agreement on July 13, 2018 (SSA), Northern TK Venture Pte Ltd (NTK or the Acquirer), a wholly owned subsidiary of IHH Berhard, subscribed to 235,294,117 new equity shares of Fortis Healthcare Limited (FHL) with a face value of Rs 10 each, constituting approximately 31.1% of the total voting equity share capital of FHL on a fully diluted basis for a total consideration of Rs 4,000 crore and FHL issued and allotted the Subscription Shares by way of preferential allotment in accordance with the terms of the SSA. As a consequence of Subscription, the Acquirer together with IHH Healthcare Berhad (PAC 1) and Parkway Pantai Limited (PAC 2), made a mandatory Open Offer, by filing a Public Announcement dated July 13, 2018. The Subscription completed in accordance with the terms of the SSA on November 13, 2018 and NTK became the controlling shareholder of FHL.In 202425, Company had sold its business operations pertaining to Malar Hospital, as a going concern via slump sale on February 01, 2024. Post this sale, Company ceased to have any business operations in 2024.

Fortis Malar Hospitals reported a Q2 FY2025–2026 revenue of ₹0.02 crore, down -95.9% YoY, with net profit decreased -99.1% to ₹4.15 crore. For the full year FY2025–2026, revenue reached ₹2.72 crore and profit touched at ₹0.39 crore. As of Jun '25, Fortis Malar Hospitals’s market capitalisation stood at ₹128.25 crores. Shareholding as of Jun '25 shows promoters holding 62.7%, with FIIs at 0.1%, DIIs at 37.2%, and public at %.

As of 18 Aug, 2025, Fortis Malar Hospitals share price is ₹68.7. The stock opened at ₹73 and had closed at ₹68.4 the previous day. During today’s trading session, Fortis Malar Hospitals share price moved between ₹68.52 and ₹72.97, with an average price for the day of ₹70.75. Over the last 52 weeks, the stock has recorded a low of ₹51.01 and a high of ₹98.70. In terms of performance, Fortis Malar Hospitals share price has increased by 18.4% over the past six months and has increased by 12.59% over the last year.